Pharma industry paying sharp attention to prosecution’s addition investigation

Pharmaceutical companies have paid sharp attention to the result of the Novartis’ rebate case.

According to the pharmaceutical industry, while the trial for Novartis and some of the press is scheduled to be held on the 29^th of November, whether the prosecution will have additional investigations has risen as a pressing matter of the industry.

This is because the pharmaceutical industry believ...